Pruritus, commonly called itching, is a distressing sensation that prompts the urge to scratch. Pruritus has various underlying causes, including skin diseases, systemic diseases, neurological disorders, and psychological conditions. The main types of pruritus are acute, chronic, generalized, and localized. Currently, there are limited treatment options available to effectively manage pruritus.

The global pruritus therapeutics market is estimated to be valued at US$ 81.38 Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.

Growing research in novel drug discovery and increasing investment from key market players for developing targeted drugs are expected to drive the market growth.

Key Takeaways

Key players operating in the pruritus therapeutics market are Levantina, Polycor, Indian Natural Stones, Topalidis, Dermitzakis, Antolini, Amso, Pakistan Onyx Marble & Granite, Etgran, Mumal Marbles, Tepia, Arizona Tile, Vetter Stone, Tekmarble & Granite, Temerty Stone, Dal Tile, M S International, Pokarna Limited, and Cosentino. These players are actively involved in new product launches and collaborations to strengthen their presence in the market.

The key opportunities in the market include increasing awareness among patients, growth in demand for advanced treatment options, and expansion in emerging economies. The market players are focusing on these regions for global expansion due to large population size and growing medical tourism in these areas.

Market Drivers:

Rising prevalence of chronic pruritic conditions like atopic dermatitis, psoriasis and chronic kidney disease is driving the Pruritus Therapeutics Market Size. According to a report by AAD, over 31 million Americans had atopic dermatitis in 2018. In addition, increasing research on novel drugs that selectively target itch sensation without damaging sensations will further propel market growth.

Market Restrains:

High cost of pruritus treatment inhibits patients from seeking medical help. Secondly, lack of disease-specific approved drugs for managing various types of pruritus poses a challenge in market growth. Most drugs available are used off-label. Long development timelines and failure of drugs in clinical trials also hampers new product launches. Strict regulations for drug approval further restrains the market.

Get more insights on Pruritus Therapeutics Market